Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy

被引:0
|
作者
Riccardo Giampieri
Elena Maccaroni
Alessandra Mandolesi
Michela Del Prete
Kalliopi Andrikou
Luca Faloppi
Alessandro Bittoni
Maristella Bianconi
Marina Scarpelli
Raffaella Bracci
Mario Scartozzi
Stefano Cascinu
机构
[1] Azienda Ospedaliero Universitaria Ospedali Riuniti,Department of Medical Oncology
[2] Università Politecnica delle Marche,Department of Pathology
[3] Università Politecnica delle Marche,Department of Medical Oncology
[4] Università di Cagliari,undefined
来源
Gastric Cancer | 2017年 / 20卷
关键词
Gastric cancer; Mismatch repair; Microsatellite instability; Chemotherapy; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:156 / 163
页数:7
相关论文
共 50 条
  • [41] Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients
    Ichikawa, W.
    Sasaki, Y.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1665 - 1672
  • [42] Efficacy of pembrolizumab as first-line therapy in patients with mismatch repair-deficient metastatic colorectal cancer in relation to the metastatic site.
    Ardestani, Bahar Saberzadeh
    Jones, Jeremy Clifton
    Hubbard, Joleen M.
    McWilliams, Robert R.
    Halfdanarson, Thorvardur Ragnar
    Shi, Qian
    Sonbol, Bassam Bassam
    Ticku, Jonathan
    Jin, Zhaohui
    Sinicrope, Frank A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 57 - 57
  • [43] Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy
    Wang, Zhuo
    Zhang, Liqun
    Wang, Jingyan
    Wang, Yuanhe
    Dong, Qian
    Piao, Haiyan
    Wang, Qiwei
    Zhang, Jingdong
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [44] Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy
    Castro-Rojas, Carlos
    Ortiz-Lopez, Rocio
    Rojas-Martinez, Augusto
    INVESTIGACION CLINICA, 2014, 55 (02): : 185 - 202
  • [45] Erratum: Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
    L Paré
    E Marcuello
    A Altés
    E del Río
    L Sedano
    J Salazar
    A Cortés
    A Barnadas
    M Baiget
    British Journal of Cancer, 2009, 100 : 1368 - 1368
  • [46] Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy
    May, Sarah B.
    La, Jennifer
    Milner, Emily
    Riaz, Nimrah
    Amos, Christopher, I
    Garcia, David A.
    Carrier, Marc
    Zakai, Neil
    Do, Nhan, V
    Brophy, Mary
    Chitalia, Vipul
    Gaziano, J. Michael
    Fillmore, Nathanael
    Li, Ang
    BLOOD, 2022, 140 : 7968 - 7970
  • [47] A CIRCULATING EXOSOMAL MICRORNA SIGNATURE FOR THE NONINVASIVE PREDICTION OF RESPONSE TO THE FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC GASTRIC CANCER
    Okuno, Keisuke
    Watanabe, Shuichi
    Hur, Hoon
    Lee, Jeeyun
    Tokunaga, Masanori
    Kinugasa, Yusuke
    Goel, Ajay
    GASTROENTEROLOGY, 2023, 164 (06) : S766 - S766
  • [48] First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
    Hwang, Jun-Eul
    Kim, Ha-Na
    Kim, Dae-Eun
    Shim, Hyun-Jeong
    Bae, Woo-Kyun
    Hwang, Eu-Chang
    Cho, Sang-Hee
    Chung, Ik-Joo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (04) : 562 - 568
  • [49] A Comparison of Weekly DCF versus Standard DCF as First-line Systemic Chemotherapy for Metastatic Gastric Cancer Patients
    Aldemir, M. N.
    Turkeli, M.
    Simsek, M.
    Yildirim, N.
    Bilici, M.
    Dogan, C.
    Tekin, S. B.
    WEST INDIAN MEDICAL JOURNAL, 2023, 70 (01): : 18 - 22
  • [50] Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy
    Huang, Ming-Yii
    Huang, Meng-Lin
    Chen, Ming-Jenn
    Lu, Chien-Yu
    Chen, Chin-Fan
    Tsai, Pei-Chien
    Chuang, Shih-Chang
    Hou, Ming-Feng
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 18 - 25